A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients
primary studies published RCT
Details- 2015
- Elborn JS
Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial.
primary studies published RCT
Details- 2015
- Forrester DL
Efficacy response in CF patients treated with ivacaftor: Post-hoc analysis.
primary studies published RCT
Details- 2015
- Konstan MW
Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.
primary studies published RCT
Details- 2015
- Moss RB
Behavioral and nutritional treatment for preschool-aged children with cystic fibrosis: a randomized clinical trial.
primary studies published RCT
Details- 2015
- Powers SW
Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: Patient-reported outcomes in the STRIVE randomized, controlled trial.
primary studies published RCT
Details- 2015
- Quittner A
Tiotropium Respimat(R) in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials.
primary studies published RCT
Details- 2015
- Ratjen F
Active Video Game Playing in Children and Adolescents With Cystic Fibrosis: Exercise or Just Fun?
primary studies published RCT
Details- 2015
- Salonini E
Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients
primary studies published RCT
Details- 2015
- Sawicki GS
Choline Supplementation with a Structured Lipid in Children with Cystic Fibrosis: A Randomized Placebo-Controlled Trial.
primary studies published RCT
Details- 2015
- Schall JI